Ligand profile
ZINC248005837
Virtual-screening candidate from ZINC.
Bound to: KP13_03192 — Periplasmic beta-glucosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC248005837- UniProt (similar protein)
Q9XEI3- Tanimoto
- 0.714
- Target protein
- KP13_03192
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 180.3
- −1 ≤ LogP ≤ 5 -4.68
- MW ≤ 500 Da 358.4
- LogP ≤ 5 -4.68
- H-bond donors ≤ 5 8
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 180.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
OC[C@@H]1O[C@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1OOC[C@@H]1O[C@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
InChI=1S/C12H22O10S/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4+,5+,6-,7-,8-,9+,10-,11+,12-/m0/s1InChI=1S/C12H22O10S/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4+,5+,6-,7-,8-,9+,10-,11+,12-/m0/s1
SYKYBMOFPMXDRQ-GBSARZEWSA-NSYKYBMOFPMXDRQ-GBSARZEWSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 6BV
- Homolog
- Q9XEI3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC248005837 →
- ZINC ZINC20 ZINC248005837 →
- UniProt UniProt Q9XEI3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC248005837”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03192.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).